Accelerated approvals examined

被引：0
|
作者：
Emma Dorey
机构：
来源：
Nature Biotechnology | 2011年 / 29卷 / 3期
关键词：
D O I：
10.1038/nbt0311-176b
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：176 / 176
相关论文
共 50 条
  • [31] Chemical changes in powder reference materials examined by accelerated ageing methods
    D. G. Lisienko
    N. V. Ul'yanova
    [J]. Measurement Techniques, 1999, 42 : 1097 - 1101
  • [32] Chemical changes in powder reference materials examined by accelerated ageing methods
    Lisienko, DG
    Ul'yanova, NV
    [J]. MEASUREMENT TECHNIQUES, 1999, 42 (11) : 1097 - 1101
  • [33] Access to new therapies: FDA accelerated approvals and the corresponding Canadian regulatory and funding decisions.
    Lim, Howard John
    Hunt, Melissa
    Beaver, Julia A.
    Kluetz, Paul Gustav
    Gravel, Christopher
    Raven, Andrew
    Regier, Dean
    Ho, Cheryl
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Value assessment of immuno-oncology in the treatment of rare tumors in the era of accelerated conditional approvals
    Lanitis, Tereza
    Ambavane, Apoorva
    Zheng, Ying
    Schlichting, Michael
    Phatak, Hemant
    [J]. FUTURE ONCOLOGY, 2019, 15 (35) : 4057 - 4067
  • [35] Approvals
    不详
    [J]. BIOPHARM INTERNATIONAL-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2004, 17 (02): : 12 - 12
  • [36] Approvals
    不详
    [J]. MANUFACTURING ENGINEERING, 2002, 129 (01): : 22 - 22
  • [37] BEYOND CONVENTIONAL CLINICAL VALUE: ESTIMATING THE IMPACT OF ACCELERATED APPROVALS ON THERAPEUTIC BRIDGING BETWEEN INNOVATIVE THERAPIES
    Wong, W.
    Kowal, S.
    To, T. M.
    Patel, A.
    Veenstra, D.
    Garrison, L.
    Li, M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S211 - S212
  • [38] The FDA's latest draft guidance on accelerated approvals - one step forward, two steps back?
    Benjamin, David J.
    Lythgoe, Mark P.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (09) : 577 - 578
  • [39] EVIDENTIARY CRITERIA FOR ACCELERATED APPROVAL OF NEW MEDICINES: CATALOGING FDA'S FLEXIBILITY IN SUBPART H APPROVALS
    Sasinowski, F.
    Varond, A.
    [J]. MUSCLE & NERVE, 2014, 50 : S1 - S2
  • [40] Accelerated vs. regular approval: Lessons learned from US FDA oncology approvals.
    Leao, Ihid Carneiro
    Blumenthal, Gideon Michael
    Reaman, Gregory H.
    Pazdur, Richard
    Liu, Ke
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345